000 01404 a2200409 4500
005 20250512180400.0
264 0 _c19690409
008 196904s 0 0 eng d
022 _a0038-4348
024 7 _a10.1097/00007611-196901000-00006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTysinger, D S
245 0 0 _aTreatment phase of the Alabama chronic respiratory disease program.
_h[electronic resource]
260 _bSouthern medical journal
_cJan 1969
300 _a23-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlabama
650 0 4 _aAnabolic Agents
_xtherapeutic use
650 0 4 _aBreathing Exercises
650 0 4 _aBronchitis
_xtherapy
650 0 4 _aBronchodilator Agents
_xtherapeutic use
650 0 4 _aExpectorants
_xtherapeutic use
650 0 4 _aFollow-Up Studies
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPrognosis
650 0 4 _aPulmonary Emphysema
_xtherapy
650 0 4 _aRespiratory Function Tests
650 0 4 _aRespiratory Tract Diseases
_xtherapy
650 0 4 _aSmoking
650 0 4 _aSympathomimetics
_xtherapeutic use
650 0 4 _aXanthines
_xtherapeutic use
700 1 _aWalton, R A
700 1 _aAdams, C N
773 0 _tSouthern medical journal
_gvol. 62
_gno. 1
_gp. 23-9
856 4 0 _uhttps://doi.org/10.1097/00007611-196901000-00006
_zAvailable from publisher's website
999 _c5766993
_d5766993